Additional analyses also suggest that the lack of impact of the intervention on anemia, in spite of a significant impacts on Hb, may be due to the fact that Hb levels remained low (below the 11 g/dL cut-off point that defines anemia) at each measurement. This evidence concerns the gene GSTM1 and anemia.